<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>"ADHERENCE TO ANTIRETROVIRAL THERAPY IN HIV-POSITIVE CHILDREN AND ADOLESCENTS: CHALLENGES AND STRATEGIES FOR IMPROVEMENT"</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Laziz</mods:namePart><mods:namePart type="family">Tuychiev</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Gulnara</mods:namePart><mods:namePart type="family">Khudaykulova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Khumoyun Mirzo</mods:namePart><mods:namePart type="family">Sadikov</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>HIV remains a significant global health challenge, particularly among vulnerable populations such as children. Despite advancements in antiretroviral therapy (ART), adherence among children and adolescents is suboptimal, leading to treatment failure and the risk of viral resistance. Addressing barriers to adherence is essential to improving clinical outcomes and ensuring long-term success in managing pediatric HIV.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-01-25</mods:dateIssued></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>